Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001013762-25-000233
Filing Date
2025-03-06
Accepted
2025-03-06 21:55:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8050
  Complete submission text file 0001013762-25-000233.txt   9627
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
STEINMAN LAWRENCE (Filed by) CIK: 0001132679 (see all company filings)

State of Incorp.: DE
Type: SCHEDULE 13D/A

Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92867 | Film No.: 25717401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)